Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT04038840
PHASE1

Imaging Synapses With [11C] UCB-J in the Human Brain

Sponsor: Davidzon, Guido, M.D.

View on ClinicalTrials.gov

Summary

The purpose of this study is to utilize the radioactive positron emission tomography (PET) tracer \[11C\]UCB-J to test the neural synaptic pruning hypothesis of schizophrenia. This imaging method allows for the quantification of synaptic density in the living human brain and has the unprecedented ability to directly examine the synaptic pathology underlying neuropsychiatric disease. The neural synaptic pruning hypothesis posits that a key pathogenic process of schizophrenia is the over-exuberant elimination of neural synapses during development. The confirmation of reduced synaptic density in schizophrenia as evidenced by \[11C\]UCB-J has the potential to lead to a number of ground-breaking clinical innovations, such as laboratory-based diagnostics and prognostics, and novel, disease-modifying treatments.

Key Details

Gender

All

Age Range

18 Years - 65 Years

Study Type

INTERVENTIONAL

Enrollment

60

Start Date

2019-08-01

Completion Date

2025-12

Last Updated

2024-12-16

Healthy Volunteers

Yes

Conditions

Interventions

DRUG

[11C]UCB-J radiotracer

I.V. bolus administration of up to 15 mCi (equivalent to 0.3 rems) in the antecubital vein

DEVICE

PET-MR

Positron emission tomography and magnetic resonance imaging, with a scan duration of up to 120 minutes

Locations (2)

VA Palo Alto Health Care System

Palo Alto, California, United States

Stanford University

Stanford, California, United States